LUNG Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: May 08, 2026

Report Source: 2026 1st Quarter Report

Analyst's Ratings for Pulmonx Corp (LUNG)

Based on 12 analysts giving stock ratings to Pulmonx Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
25
Buy
50
Hold
25
Sell
0
Strong Sell
0
Pulmonx Corp

Pulmonx Corp. Stock Analysis LUNG

United States Health Care Micro Cap Report:
Pulmonx Corp. is a medical technology company, which engages in the provision of interventional pulmonology, planning tools and treatments for obstructive lung diseases. The company is headquartered in Redwood City, California and currently employs 296 full-time employees. The company went IPO on 2020-10-01. The firm provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a cloud-based quantitative CT (QCT) analysis service that provides physicians with multiple products, LungTraX Connect, to improve workup efficiency, LungTraX Detect, to enable patient identification and an easy-to-read StratX Lung report that it designed for its solution that includes information on emphysema destruction, fissure completeness and lobar volume to help identify target lobes for treatment with Zephyr Valves. The Chartis System is a proprietary balloon catheter and console system with flow and pressure sensors designed to assess the presence of collateral ventilation.
Read More

Pulmonx Corp (LUNG) Chart

Key Statistics of Pulmonx Corp (LUNG)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$1.25$1.33

Today's Open

$1.33

Volume

275.27K

P/E Ratio (TTM)

-

52 Week Range

$1.13$3.88

Market Cap

53.64M

Avg. Volume

525.89K

Dividend Yield

-

Financial Metrics & Statements of Pulmonx Corp (LUNG)

FAQ's for Pulmonx Corp (LUNG)

  • According to Musaffa’s Shariah screening methodology, Pulmonx Corp (LUNG) is currently classified as HALAL as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.